Overview

Efficacy and Safety of Telitacicept in Early SLE

Status:
Recruiting
Trial end date:
2025-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of Telitacicept in adult patients with early stage of SLE .
Phase:
Phase 4
Details
Lead Sponsor:
Peking Union Medical College Hospital
Collaborator:
RemeGen Co., Ltd.